https://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Sanofi-le-Dupixent-est-le-1er-medicament-a-reduire-les-symptomes-du-prurigo-nodulaire-36749814/?utm_source=telegram&utm_medium=social&utm_campaign=share